title: The identification of insulin saturation effects during the dynamic insulin sensitivity test.
abstract: BACKGROUND
  Many insulin sensitivity (SI) tests identify a sensitivity metric that is proportional to the total available insulin and measured glucose disposal despite general acceptance that insulin action is saturable. Accounting for insulin action saturation may aid inter-participant and/or inter-test comparisons of insulin efficiency, and model-based glycaemic regulation.
  
  
  METHODS
  Eighteen subjects participated in 46 dynamic insulin sensitivity tests (DIST, low-dose 40-50 minute insulin-modified IVGTT). The data was used to identify and compare SI metrics from three models: a proportional model (SI(L)), a saturable model (SI(S )and Q₅₀) and a model similar to the Minimal Model (SG and SI(G)). The three models are compared using inter-trial parameter repeatability, and fit to data.
  
  
  RESULTS
  The single variable proportional model produced the metric with least intra-subject variation: 13.8% vs 40.1%/55.6%, (SI(S)/I₅₀) for the saturable model and 15.8%/88.2% (SI(G)/SG) for the third model. The average plasma insulin concentration at half maximum action (I₅₀) was 139.3 mU·L⁻¹, which is comparable to studies which use more robust stepped EIC protocols.
  
  
  CONCLUSIONS
  The saturation model and method presented enables a reasonable estimation of an overall patient-specific saturation threshold, which is a unique result for a test of such low dose and duration. The detection of previously published population trends and significant bias above noise suggests that the model and method successfully detects actual saturation signals. Furthermore, the saturation model allowed closer fits to the clinical data than the other models, and the saturation parameter showed a moderate distinction between NGT and IFG-T2DM subgroups. However, the proposed model did not provide metrics of sufficient resolution to enable confidence in the method for either SI metric comparisons across dynamic tests or for glycamic control.
authors: Centre for Bio-Engineering, University of Canterbury, Christchurch, New Zealand.
authors: Paul D
authors: PD
authors: Docherty
authors: J Geoffrey
authors: JG
authors: Chase
authors: Christopher E
authors: CE
authors: Hann
authors: Thomas F
authors: TF
authors: Lotz
authors: J
authors: J
authors: Lin
authors: Kirsten A
authors: KA
authors: McAuley
authors: Geoffrey M
authors: GM
authors: Shaw
references: Diabetes. 1999 May;48(5):1070-81
references: 10331412
references: J Clin Endocrinol Metab. 2003 Dec;88(12):5875-80
references: 14671184
references: J Clin Invest. 1996 Mar 15;97(6):1497-503
references: 8617883
references: Comput Methods Programs Biomed. 2007 Oct;88(1):52-61
references: 17707944
references: Endocr Rev. 1985 Winter;6(1):45-86
references: 3884329
references: Am J Physiol. 1979 Jun;236(6):E667-77
references: 443421
references: Diabetes Care. 2007 Sep;30(9):2411-3
references: 17726193
references: Am J Physiol. 1979 Sep;237(3):E214-23
references: 382871
references: Crit Care. 2008;12(2):R49
references: 18412978
references: Am J Physiol Endocrinol Metab. 2000 May;278(5):E794-801
references: 10780934
references: Comput Methods Programs Biomed. 2008 Mar;89(3):215-25
references: 18242418
references: J Clin Invest. 1994 Jan;93(1):10-6
references: 8282776
references: Environ Technol. 2007 Feb;28(2):205-16
references: 17396415
references: Am J Physiol Endocrinol Metab. 2002 Mar;282(3):E564-73
references: 11832358
references: Open Med Inform J. 2009 Dec 02;3:65-76
references: 20148062
references: Comput Methods Programs Biomed. 2008 Feb;89(2):141-52
references: 17544541
references: Diabetes Technol Ther. 2004 Jun;6(3):307-18
references: 15198833
references: Am J Physiol. 1999 Jun;276(6):E1171-93
references: 10362630
references: J Diabetes Sci Technol. 2008 May;2(3):424-35
references: 19885207
references: Bull Math Biophys. 1965;27:Suppl:21-37
references: 5884133
references: J Clin Invest. 1980 Jun;65(6):1272-84
references: 6997333
references: Am J Physiol. 1981 Jun;240(6):E630-9
references: 7018254
references: J Clin Invest. 1996 Jan 15;97(2):501-7
references: 8567973
references: J Hypertens. 1998 Jul;16(7):895-906
references: 9794728
references: Diabetologia. 2009 May;52(5):752-64
references: 19283361
references: Diabetologia. 1998 Sep;41(9):1029-39
references: 9754821
references: Ann Surg. 1982 Oct;196(4):420-35
references: 6751244
references: J Clin Invest. 1990 Jun;85(6):1844-52
references: 2189893
references: Comput Methods Programs Biomed. 2010 Mar;97(3):211-22
references: 19632735
references: Diabetologia. 1997 Jun;40(6):687-97
references: 9222649
references: J Clin Invest. 1987 Mar;79(3):790-800
references: 3546379
references: Comput Methods Programs Biomed. 2005 Mar;77(3):259-70
references: 15721654
references: Diabetes. 1992 Mar;41(3):368-77
references: 1551497
references: J Clin Invest. 1989 Nov;84(5):1620-8
references: 2681272